Category: ACN Newswire

Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) IQLIK(TM) (lecanemabirmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status

TOKYO and CAMBRIDGE, Mass., Nov. 26, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: HaruoNaito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai has

More

EdgePoint and Pahang State Parks Corporation Launch Connectivity for Conservation at the Al-Sultan Abdullah Royal Tiger Reserve, Ulu Tembeling, Jerantut, Pahang

KUALA LUMPUR, Nov 25, 2025 – (ACN Newswire via SeaPRwire.com) – EdgePoint Towers Sdn Bhd (“EdgePoint”) – part of EdgePoint Infrastructure, a leading ASEAN-based independent telecommunications infrastructure company – announced the successful deployment of its first-of-its-kind Connectivity for Conservation project

More